Alpha Diagnostic International, Inc. Anti-Mouse Carnitine Palmitoyl Transferase-2 (CPT-2) antiserum CPT21-S

Anti-Mouse Carnitine Palmitoyl Transferase-2 (CPT-2) antiserum General Information Mitochondrial oxidation of LC-FCA is initiated by the sequential action of CPT-1, which is located in the outer membrane, and CPT-2, which is located in the inner membrane together with a carnitine-acylcarnit ine translocase. CPT-2 (mouse/rat/human 658-aa SugApplications Most Antibodies are tested by ELISA and Western. Additional applications, such as IHC or IP may have been tested and will be listed in the product data sheets or published research papers using our products. Typically, antibodies are tested against the SugSecAntibodies http://4adi.com/comm erce/ccc2480-seconda ry-antibodies-rabbit .htm SpeciesReactivity Mouse SugNegativeControl Non-immune Rabbit IgG Cat# 20009-1 Form Antiserum Unpurified SugPositiveControl Recombinant or naturally purified proteins or cells of tissues expressing the protein under study can be used as positive controls for Western or IHC. Please review the ?General Information? tan under Product overview section. Control or blocking peptid Antigen 16-aa peptide from mouse CPT-2L Gene Accession # P52825(1); Designation (#CPT21-P, control/blocking peptide) conjugated to KLH SpCrossreactivity The mouse CPT21-P peptide is 93% conserved in rat and 86% in human CPT-2. No significant sequence homology of CPT21-P is seen with CPT-1 or any other protein. Antibody reactivity in various species is not established. The CPT21-P Control peptide, because of its low mol. Wt (<3 kDa), is not suitable for Western. It should be used for ELISA or antibody blocking experiments (use 5-10 ug control peptide per 1 ug of aff pure IgG or 1 ul antiserum) to confirm antibody specificity For research use only, not for diagnostic or therapeutic use.